Article
Effect of the Butyrate Prodrug Pivaloyloxymethyl Butyrate (AN9) on a Mouse Model for Spinal Muscular Atrophy.
Journal of neuromuscular diseases - 29 Nov 2016
Edwards Jonathan D, Butchbach Matthew E R
Abstract excerpt
Spinal muscular atrophy (SMA) is an early-onset motor neuron disease that leads to loss of muscle function. Butyrate (BA)-based compounds markedly improve the survival and motor phenotype of SMA mice. In this study, we examine the protective effects of the BA prodrug pivaloyloxymethyl butyrate (AN9) on the survival of SMNΔ7 SMA mice. Oral administration of AN9 beginning at PND04 almost doubled the average...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
